These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 28028258)

  • 1. [Exploration of the Factors Influencing Multi-Drug Cancer Chemotherapy in the Elderly - A Retrospective Study].
    Ogata K; Tamura K; Kiyomi F; Takamatsu Y; Kamimura H
    Gan To Kagaku Ryoho; 2016 Dec; 43(13):2523-2529. PubMed ID: 28028258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fall-related injuries in elderly cancer patients treated with neurotoxic chemotherapy: a retrospective cohort study.
    Ward PR; Wong MD; Moore R; Naeim A
    J Geriatr Oncol; 2014 Jan; 5(1):57-64. PubMed ID: 24484719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Limits and value of chemotherapy in elderly patients].
    Engert A; Schnell R; Lathan B; Diehl V
    Med Klin (Munich); 1994 Nov; 89(11):603-10. PubMed ID: 7815990
    [No Abstract]   [Full Text] [Related]  

  • 4. [Side effects and complications of intra-arterial tumor therapy--experiences with 577 interventions].
    Görich J; Hasan I; Sittek H; Harder T; Rieber A; Hartlapp HJ; Keilholz U; Kunze V; Brado M; Reiser M
    Rontgenpraxis; 1995 May; 48(5):132-45. PubMed ID: 7792665
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer chemotherapy in the elderly.
    Walsh SJ; Begg CB; Carbone PP
    Semin Oncol; 1989 Feb; 16(1):66-75. PubMed ID: 2645651
    [No Abstract]   [Full Text] [Related]  

  • 6. Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.
    Oza AM; Cibula D; Benzaquen AO; Poole C; Mathijssen RH; Sonke GS; Colombo N; Špaček J; Vuylsteke P; Hirte H; Mahner S; Plante M; Schmalfeldt B; Mackay H; Rowbottom J; Lowe ES; Dougherty B; Barrett JC; Friedlander M
    Lancet Oncol; 2015 Jan; 16(1):87-97. PubMed ID: 25481791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cancer chemotherapy of high-age patients with gastrointestinal malignancies].
    Shimizu N; Sawada T; Inoue Y; Shimizu T; Murakami A; Hamazoe R; Maeta M; Koga S
    Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2752-7. PubMed ID: 2074384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
    Koo YX; Tay M; Teh YE; Teng D; Tan DS; Tan IB; Tai DW; Quek R; Tao M; Lim ST
    Ann Hematol; 2011 Oct; 90(10):1219-23. PubMed ID: 21520001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elderly breast cancer patients: adjuvant chemotherapy and adjuvant endocrine therapy.
    Biganzoli L; Aapro M
    Gynakol Geburtshilfliche Rundsch; 2005 Jun; 45(3):137-42. PubMed ID: 15990438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytostatic chemotherapy in advanced age].
    Sauer H
    Geburtshilfe Frauenheilkd; 1995 Jan; 55(1):M1-5. PubMed ID: 7705590
    [No Abstract]   [Full Text] [Related]  

  • 11. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials.
    Marsland TA; Garfield DH; Khan MM; Look RM; Boehm KA; Asmar L
    Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential drug interactions in elderly cancer patients.
    Girre V; Arkoub H; Puts MT; Vantelon C; Blanchard F; Droz JP; Mignot L
    Crit Rev Oncol Hematol; 2011 Jun; 78(3):220-6. PubMed ID: 20594867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer.
    Aggarwal C; Langer CJ
    Curr Opin Oncol; 2012 Mar; 24(2):130-6. PubMed ID: 22314616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of chemotherapy-induced nausea and vomiting in elderly cancer patients.
    Jakobsen JN; Herrstedt J
    Crit Rev Oncol Hematol; 2009 Sep; 71(3):214-21. PubMed ID: 19162507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: benefits and risks of chemotherapy in elderly patients with metastatic colorectal cancer.
    Mitry E; Rougier P
    Aliment Pharmacol Ther; 2009 Jan; 29(2):161-71. PubMed ID: 18945257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe neutropenia following cytostatic drug therapy--clinical symptoms, follow-up and prognosis in 26 patients of a district hospital].
    Radke EU; Papke J
    Z Gesamte Inn Med; 1990 Apr; 45(8):219-22. PubMed ID: 2378134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy with cytostatic drugs in the elderly].
    Sauer H
    Internist (Berl); 1991 Aug; 32(8):479-85. PubMed ID: 1938269
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy-induced emesis in elderly cancer patients: the role of 5-HT3-receptor antagonists in the first 24 hours.
    Aapro M; Johnson J
    Gerontology; 2005; 51(5):287-96. PubMed ID: 16110229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of adverse events of bevacizumab-containing systemic chemotherapy for metastatic colorectal cancer in Japan.
    Isobe T; Uchino K; Makiyama C; Ariyama H; Arita S; Tamura S; Komoda M; Kusaba H; Shirakawa T; Esaki T; Mitsugi K; Takaishi S; Akashi K; Baba E
    Anticancer Res; 2014 Apr; 34(4):2035-40. PubMed ID: 24692744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of elderly patients with antineoplastic chemotherapy.
    Tirelli U; Monfardini S
    J Clin Oncol; 1995 May; 13(5):1282-3. PubMed ID: 7738634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.